Sunday, March 7, 2021
Spread the love

CORONAVIRUS – Good news from the World Health Organisation — WHO welcomes preliminary results about dexamethasone use in treating critically ill COVID-19 patients  The World Health Organization (WHO) has welcomed the initial clinical trial results from the United Kingdom (UK) that show dexamethasone, a corticosteroid, can be lifesaving for patients who are critically ill with COVID-19. For patients on ventilators, the treatment was shown to reduce mortality by about one third, and for patients requiring only oxygen, mortality was cut by about one fifth, according to preliminary findings shared with WHO. A statement from the World Health Organisation signed by Spokesperson, Fadela Chaib reveals that the benefit was only seen in patients seriously ill with COVID-19, and was not observed in patients with milder disease.  “This is the first treatment to be shown to reduce mortality in patients with COVID-19 requiring oxygen or ventilator support,” said Dr Tedros Adhanom Ghebreyesus, WHO Director-General. “This is great news and I congratulate the Government of the UK, the University of Oxford, and the many hospitals and patients in the UK who have contributed to this lifesaving scientific breakthrough.” The WHO statement says ‘’Dexamethasone is a steroid that has been used since the 1960s to reduce inflammation in a range of conditions, including inflammatory disorders and certain cancers. It has been listed on the WHO Model List of Essential Medicines since 1977 in multiple formulations, and is currently off-patent and affordably available in most countries. Further Online checks by Terrififc Headlines indicates that ‘’dexamethasone’  is a drug used to reduce inflammation and lower the body’s immune response. It is used with other drugs to treat leukemia, lymphoma, mycosis fungoides, and other types of cancer. Dexamethasone is also used to prevent or treat many other diseases and conditions. These include conditions related to cancer and its treatment, such as anemia, allergic reactions, swelling in the brain, and high levels of calcium in the blood. Dexamethasone is a type of corticosteroid. The researchers shared initial insights about the results of the trial with WHO, and we are looking forward to the full data analysis in the coming days. WHO will coordinate a meta-analysis to increase our overall understanding of this intervention.  WHO clinical guidance will be updated to reflect how and when the drug should be used in COVID-19. Today’s news builds off the WHO Research & Development Blueprint meeting, which took place in Geneva in…

This content is for Unlimited Access and 1 Month Subscription members only.
Login Join Now
Social Media Auto Publish Powered By :